指南与共识免疫规划卫生政策与健康促进

2008-2020年挪威全脾切除术患者对疫苗接种指南的依从性

Adherence to vaccination guidelines of patients with complete splenectomy in Norway, 2008-2020.
指南 / 共识 · Vaccine · 2023-06-17

研究基于挪威患者登记系统、国家免疫登记系统和传染病监测系统,评估2008-2020年3155例全脾切除术患者的疫苗接种覆盖率。结果显示,肺炎球菌结合疫苗至少一剂覆盖率为29.0%,肺炎球菌多糖疫苗至少一剂为42.0%, Hib疫苗为18.7%;所有疫苗覆盖率随年龄增长而下降。脾切除术后共登记25例患者发生29例侵袭性细菌感染,按国家推荐接种疫苗可预防其中至少8例(28%)。

要点

  • 全脾切除术患者肺炎球菌结合疫苗至少一剂覆盖率为29.0%,肺炎球菌多糖疫苗至少一剂为42.0%。
  • Hib疫苗覆盖率为18.7%,脑膜炎球菌ACWY结合疫苗两剂覆盖率仅4.2%。
  • 所有疫苗覆盖率随年龄增长而下降;作者认为需努力提高挪威脾切除患者的疫苗覆盖率。

核心结论

  • 研究显示挪威全脾切除术患者疫苗接种覆盖率低,需努力提高接种率。

研究设计与样本

  • 基于挪威患者登记系统、国家免疫登记系统和挪威传染病监测系统的登记数据,纳入2008-2020年3155例全脾切除术患者。

主要发现

  • 914例(29.0%)患者至少接种一剂肺炎球菌结合疫苗(PCV),1324例(42.0%)至少接种一剂肺炎球菌多糖疫苗,589例(18.7%)同时接种两者。
  • 仅4.2%的患者接种两剂脑膜炎球菌ACWY结合疫苗;2014年后脾切除的1467例患者中8.0%至少接种两剂B群脑膜炎球菌疫苗。
  • Hib疫苗覆盖率为18.7%;所有疫苗覆盖率随年龄增长而下降。
  • 25例患者脾切除术后登记29例侵袭性细菌感染,按国家推荐接种疫苗可预防其中至少8例(28%)。

关键数值与推荐

  • 原文建议脾切除者接种疫苗以预防肺炎链球菌、脑膜炎奈瑟菌和b型流感嗜血杆菌(Hib)感染。

临床怎么用

  • 原文未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The spleen is responsible for blood filtration and mounting an immune response against pathogens. In some people the spleen must be surgically removed because of traumatic events or oncological and hematological conditions. These patients are at higher risk of developing diseases caused by encapsulated bacteria throughout their lives. Thus, immunisations are advised for splenectomised persons to prevent infection caused by Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae type b (Hib). This study assessed vaccination coverage (VC) among Norwegian patients with surgical asplenia. Using the Nomesco Classification of Surgical Procedures codes, patient information (age, sex, date of initial diagnosis and date of surgery) was acquired from the Norwegian Patient Registry. The National Immunization Register provided information on vaccination status and data of any subsequent invasive bacterial infections were obtained from the Norwegian Surveillance System for Communicable Diseases. From the total population of Norway, 3155 patients who had undergone complete splenectomy were identified. Of these, 914 (29.0%) had received at least one dose of pneumococcal conjugate vaccine (PCV), 1324 (42.0%) at least one dose of pneumococcal polysaccharide vaccine and 589 (18.7%) had received both. Only 4.2% of the patients had received two doses of a meningococcal ACWY conjugate vaccine, while 8.0% of 1467 patients splenectomised after 2014 had received at least two doses of a serogroup B meningococcal vaccine. The VC for Hib was 18.7%. Nearly all splenectomised children under the age of 10 were vaccinated with Hib and PCV as these vaccines are included in the childhood immunisation program. For all vaccines, VC decreased with age. Twenty-nine invasive bacterial infections were registered post-splenectomy in 25 patients. Vaccination according to national recommendations could have prevented at least 8 (28%) of these infections. Our study showed that efforts are required to increase VC of splenectomised individuals in Norway.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Orangzeb S, Watle SV, Caugant DA, et al. Adherence to vaccination guidelines of patients with complete splenectomy in Norway, 2008-2020. Vaccine. 2023. PMID: 37336662. doi:10.1016/j.vaccine.2023.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。